Simplex Trading’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-27,588
Closed -$8.91M 8913
2025
Q3
$8.91M Buy
27,588
+26,697
+2,996% +$8.3M ﹤0.01% 1043
2025
Q2
$346K Sell
891
-908
-50% -$365K ﹤0.01% 3907
2025
Q1
$782K Sell
1,799
-671
-27% -$269K ﹤0.01% 2943
2024
Q4
$911K Buy
+2,470
New +$1.03M ﹤0.01% 2929
2024
Q3
Sell
-3,231
Closed -$1.73M 8745
2024
Q2
$1.75M Buy
+3,231
New +$1.71M ﹤0.01% 2334
2024
Q1
Sell
-9,178
Closed -$4.56M 9084
2023
Q4
$4.33M Buy
+9,178
New +$4.24M ﹤0.01% 1687
2023
Q3
Sell
-2,483
Closed -$1.13M 8929
2023
Q2
$1.1M Buy
+2,483
New +$1.15M ﹤0.01% 2515
2022
Q2
Sell
-14,379
Closed -$7.11M 10198
2022
Q1
$7.06M Buy
14,379
+88
+0.6% +$40.2K 0.01% 1025
2021
Q4
$6.62M Buy
14,291
+13,077
+1,077% +$5.5M 0.01% 1029
2021
Q3
$465K Sell
1,214
-1,786
-60% -$679K ﹤0.01% 4204
2021
Q2
$1.15M Buy
+3,000
New +$1.15M ﹤0.01% 2911
2020
Q4
Sell
-7,473
Closed -$2.29M 8511
2020
Q3
$2.01M Buy
7,473
+3,488
+88% +$939K ﹤0.01% 1526
2020
Q2
$1.05M Sell
3,985
-44,917
-92% -$12M ﹤0.01% 2111
2020
Q1
$11.1M Buy
+48,902
New +$13.3M 0.02% 377
2019
Q4
Sell
-21,966
Closed -$6.04M 7431
2019
Q3
$5.27M Sell
21,966
-21,759
-50% -$5.96M 0.02% 690
2019
Q2
$12.3M Buy
43,725
+40,197
+1,139% +$11M 0.03% 339
2019
Q1
$1.01M Buy
+3,528
New +$1.02M ﹤0.01% 1991
2017
Q3
Sell
-162
Closed -$30.8K 6042
2017
Q2
$30K Sell
162
-174
-52% -$31.3K ﹤0.01% 2883
2017
Q1
$55K Sell
336
-16,803
-98% -$2.67M ﹤0.01% 2266
2016
Q4
$2.46M Buy
17,139
+2,413
+16% +$323K 0.15% 120
2016
Q3
$1.84M Buy
+14,726
New +$1.9M 0.13% 144
2016
Q2
Sell
-7,876
Closed -$1.08M 5929
2016
Q1
$1.09M Sell
7,876
-4,231
-35% -$565K 0.09% 204
2015
Q4
$1.69M Buy
+12,107
New +$1.67M 0.13% 123
2015
Q2
Sell
-425
Closed -$67.9K 5329
2015
Q1
$65K Buy
425
+126
+42% +$17.9K 0.01% 1376
2014
Q4
$38K Buy
+299
New +$36.9K ﹤0.01% 1560

Other funds holding ELV

Simplex Trading's ELV Position: Q4 2025 in Review

Simplex Trading sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 27,588 shares — an estimated $8.91M sold.

Simplex Trading first reported a position in ELV in Q4 2014 and held it in 25 quarters. The position peaked at $12.3M in Q2 2019. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Simplex Trading reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 27,588 Elevance Health shares in Q4 2025, an estimated $8.91M.
  • Simplex Trading first reported a position in Elevance Health in Q4 2014 and held it in 25 quarters.
  • Simplex Trading's Elevance Health position peaked at $12.3M in Q2 2019.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.